Explore the latest findings from a real-world data analysis on the effectiveness of immunotherapy in treating metastatic biliary tract cancer (mBTC) with spe…
Preliminary data show that AVA6000 led to robust and clinically meaningful tumor shrinkage in patients with salivary gland cancer.
Bevacizumab’s survival benefits in CRC patients persist for about 2 years after starting treatment.
First-line IMM-1-104 plus chemotherapy produced responses and disease control in patients with pancreatic cancer.
Zhang et al. investigate immune cell dynamics in TNBC patients treated with paclitaxel, nab-paclitaxel, and combinations with atezolizumab. They identify distinct underlying cellular mechanisms, revealing that…
Although gallbladder and bile duct cancers are different diseases, they’re often discussed together. They each have a connection to bile, a fluid that helps with…
Did you know that drinking alcohol can have lasting effects on a young person’s brain? From memory issues to cognitive testing, the impact is real.…
Get the inside scoop from Drs Lou, Patel, and Beg on the top takeaways to come out of the 2025 Gastrointestinal Cancers Symposium.
